AI-Supported Mammography Screening Shows Favourable Outcomes Compared with Standard Double Reading By Ogkologos - February 12, 2026 50 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the MASAI study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Acalabrutinib with Venetoclax for CLL or SLL No OS Improvement with CDK4/6 Inhibitors Used in First- Compared with Second-Line Treatment in Patients with HR-positive, HER2-negative ABC Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation in Patients with TP53 Y220C-mutated Solid Tumours MOST POPULAR The Pesticide Chemical Responsible For Mass Bee Die-Offs Is Killing Birds... August 20, 2020 ESMO Congress 2024 Barcelona, Spain, 13-17 September September 3, 2024 A Combination of Trastuzumab with Gemcitabine and Cisplatin Shows Promising Activity... November 24, 2023 Approximately 1 Million of New Maternal Orphans Due to Cancer in... November 28, 2022 Load more HOT NEWS Targeting FGFR1 in Patients with Tumour-Induced Osteomalacia ASCO Annual Meeting 2023: Trastuzumab Deruxtecan Effectively Treats HER2-Expressing Tumors and... Why consistent and funded cancer policies are key to improving cancer... FDA Approves Crizotinib for ALK-positive Inflammatory Myofibroblastic Tumour
